Rodolphe GAUDET - Academia.edu (original) (raw)

Rodolphe GAUDET

Related Authors

Federico Prefumo

Nisha Mary

City university of Science and information Technology Peshawar

Uploads

Papers by Rodolphe GAUDET

Research paper thumbnail of Correlations between serum assays of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) and pre-eclampsia or intrauterine growth restriction (IUGR) among nulliparas younger than 38 years

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2001

Objective: To study the relation between serum human chorionic gonadotrophin (hCG) levels measure... more Objective: To study the relation between serum human chorionic gonadotrophin (hCG) levels measured at 15±18 weeks and gestational disorders, assess their correlation with the artery uteroplacental Doppler (AUD) at 24 weeks among nulliparas, and assess the predictivity of the hCG/hPL (human placental lactogen) ratio for pre-eclampsia. Study Design: Retrospective study of two groups of women younger than 38 years old: one with an elevated serum hCG level (2 MoM (multiples of the median) or more) and a normal fetal karyotype (group A), and the other with a lower hCG level (group B). Within each group, we studied the nulliparas separately (respectively groups AO and BO). We analyzed the double screening, elevated hCG levels with abnormal AUD, for the predicting of hypertensive disorders. Results: Elevated hCG levels were signi®cantly (p<0.05) more prevalent among women who developed gestational diabetes (groups A and AO) and among nulliparas with pregnancy-induced hypertension and pre-eclampsia (AO). Among nulliparas, the combination of the hCG assay and a subsequent Doppler increased the positive predictive value (PPV) of the assay from 19 to 75%, without reducing its negative predictive value (NPV) for gestational vascular disorders. The hCG/hPL ratio did not improve the predictivity of the hCG assay alone for pre-eclampsia. Conclusions: An hCG level of 2 MoM or more at 15±18 weeks identi®es a group of women at risk of gestational vascular disorders; it therefore ought to lead to an AUD at 24 weeks. This double screening should be able to de®ne a population of women at risk of developing a hypertensive disorder, who could thus bene®t from a preventive treatment, as aspirin.

Research paper thumbnail of Fetal Impact of Cholestasis of Pregnancy: Experience at Tenon Hospital and Literature Review

Fetal Diagnosis and Therapy, 2000

Cholestasis of pregnancy is a liver disorder that occurs during the second half of pregnancy, cau... more Cholestasis of pregnancy is a liver disorder that occurs during the second half of pregnancy, causing pruritus and elevated serum bile acid levels. Its etiology remains unknown but probably involves vascular and humoral immune responses, mediated by bile acids. This disorder is associated with substantially increased fetal morbidity and mortality. The most satisfactory treatment consists in delivering the fetus as soon as pulmonary maturation has occurred.

Research paper thumbnail of Prenatal Diagnosis of a Congenital Bladder Diverticulum

Fetal Diagnosis and Therapy, 1999

A case of congenital bladder diverticulum diagnosed at 37 weeks of gestation (measured from the f... more A case of congenital bladder diverticulum diagnosed at 37 weeks of gestation (measured from the first day after the last day of the last menstrual period) is reported. Delivery took place 24 h later. A postnatal urologic work-up confirmed the diagnosis of asymptomatic congenital bladder diverticulum. The infant underwent laparotomic surgery at the age of 6 months, with an extravesical diverticulectomy and ureteral reimplantation. There were no complications. This is the first case reported in the literature of a prenatal diagnosis of a congenital bladder diverticulum. This new aspect allows early management and avoidance of the diagnostic meanders to which the discovery of a pelvic mass might lead, as well as the complications that can follow bladder diverticula.

Research paper thumbnail of Correlations between serum assays of human chorionic gonadotrophin (hCG) and human placental lactogen (hPL) and pre-eclampsia or intrauterine growth restriction (IUGR) among nulliparas younger than 38 years

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2001

Objective: To study the relation between serum human chorionic gonadotrophin (hCG) levels measure... more Objective: To study the relation between serum human chorionic gonadotrophin (hCG) levels measured at 15±18 weeks and gestational disorders, assess their correlation with the artery uteroplacental Doppler (AUD) at 24 weeks among nulliparas, and assess the predictivity of the hCG/hPL (human placental lactogen) ratio for pre-eclampsia. Study Design: Retrospective study of two groups of women younger than 38 years old: one with an elevated serum hCG level (2 MoM (multiples of the median) or more) and a normal fetal karyotype (group A), and the other with a lower hCG level (group B). Within each group, we studied the nulliparas separately (respectively groups AO and BO). We analyzed the double screening, elevated hCG levels with abnormal AUD, for the predicting of hypertensive disorders. Results: Elevated hCG levels were signi®cantly (p<0.05) more prevalent among women who developed gestational diabetes (groups A and AO) and among nulliparas with pregnancy-induced hypertension and pre-eclampsia (AO). Among nulliparas, the combination of the hCG assay and a subsequent Doppler increased the positive predictive value (PPV) of the assay from 19 to 75%, without reducing its negative predictive value (NPV) for gestational vascular disorders. The hCG/hPL ratio did not improve the predictivity of the hCG assay alone for pre-eclampsia. Conclusions: An hCG level of 2 MoM or more at 15±18 weeks identi®es a group of women at risk of gestational vascular disorders; it therefore ought to lead to an AUD at 24 weeks. This double screening should be able to de®ne a population of women at risk of developing a hypertensive disorder, who could thus bene®t from a preventive treatment, as aspirin.

Research paper thumbnail of Fetal Impact of Cholestasis of Pregnancy: Experience at Tenon Hospital and Literature Review

Fetal Diagnosis and Therapy, 2000

Cholestasis of pregnancy is a liver disorder that occurs during the second half of pregnancy, cau... more Cholestasis of pregnancy is a liver disorder that occurs during the second half of pregnancy, causing pruritus and elevated serum bile acid levels. Its etiology remains unknown but probably involves vascular and humoral immune responses, mediated by bile acids. This disorder is associated with substantially increased fetal morbidity and mortality. The most satisfactory treatment consists in delivering the fetus as soon as pulmonary maturation has occurred.

Research paper thumbnail of Prenatal Diagnosis of a Congenital Bladder Diverticulum

Fetal Diagnosis and Therapy, 1999

A case of congenital bladder diverticulum diagnosed at 37 weeks of gestation (measured from the f... more A case of congenital bladder diverticulum diagnosed at 37 weeks of gestation (measured from the first day after the last day of the last menstrual period) is reported. Delivery took place 24 h later. A postnatal urologic work-up confirmed the diagnosis of asymptomatic congenital bladder diverticulum. The infant underwent laparotomic surgery at the age of 6 months, with an extravesical diverticulectomy and ureteral reimplantation. There were no complications. This is the first case reported in the literature of a prenatal diagnosis of a congenital bladder diverticulum. This new aspect allows early management and avoidance of the diagnostic meanders to which the discovery of a pelvic mass might lead, as well as the complications that can follow bladder diverticula.

Log In